BleoGet (Bleomycin) 15 units Injection

- Generic name
- Bleomycin (as Sulfate)
- Strength
- 15 units
- Dosage form
- Lyophilized Powder for Injection (IM/IV/SC)
- Prescription
- Prescription only (Rx)
Used for
Indications
Bleomycin is indicated for palliation and treatment of squamous cell carcinomas (skin, head/neck, esophagus, larynx, penis, cervix, bronchus), choriocarcinoma, testicular embryonal cell carcinoma, Hodgkin's disease, lymphomas, and mycosis fungoides.
Dosage and administration
Administer 10-20 units/m² weekly or twice weekly via IM, IV, SC, or intra-arterial routes. Limit total dose to 300 units; lymphoma patients require initial 1-5 unit test doses.
How to order Bleomycin in the Philippines
- Tell us who is ordering. Patient or family, doctor, pharmacy or hospital.
- Share your prescription. Upload it securely with your inquiry.
- Get a formal quote. Our pharmacist reviews your order and confirms the price.
- Receive your medicine. Delivered across Luzon, Visayas and Mindanao.
Frequently asked questions
How do I order BleoGet in the Philippines?
Send an inquiry on this page or message Getmeds on WhatsApp. Choose who is ordering (patient or family, doctor, pharmacy or hospital), share a valid prescription, and our team replies with a formal quote.
How much does BleoGet (Bleomycin) cost in the Philippines?
Getmeds does not list online prices for prescription medicines. Send an inquiry with your prescription and our pharmacist sends you a formal price quote.
Do I need a prescription to buy BleoGet?
Yes. It is a prescription-only (Rx) medicine. A valid prescription from a licensed healthcare professional is required for purchase and dispensing, as regulated by FDA Philippines under RA 9711.
Does Getmeds deliver BleoGet nationwide?
Yes. Getmeds delivers prescription medicines across Luzon, Visayas and Mindanao.
Prescription medicine, supplied by Getmeds, an FDA Philippines-licensed distributor. Product registrations can be checked with the Food and Drug Administration Philippines. Request a quotation.

